Amicar and Intertrigo - a phase IV clinical study of FDA data
Summary:
Intertrigo is reported as a side effect among people who take Amicar (aminocaproic acid), especially for people who are male, 60+ old, also take Morphine, and have Aortic valve incompetence.
The phase IV clinical study analyzes which people have Intertrigo when taking Amicar. It is created by eHealthMe based on reports of 1,317 people who have side effects when taking Amicar from the FDA, and is updated regularly.
What is Amicar?
Amicar has active ingredients of aminocaproic acid. eHealthMe is studying from 1,323 Amicar users. Check the latest studies of Amicar.
What is Intertrigo?
Intertrigo (inflammation (rash) of the body folds (adjacent areas of skin)) is found to be associated with 169 drugs and 207 conditions by eHealthMe. Check the latest studies of Intertrigo.
1,317 people reported to have side effects when taking Amicar.
Among them, 9 people (0.68%) have Intertrigo.

Among these 9 people:
What is the gender of people who have Intertrigo when taking Amicar? *
- female: 0.0 %
- male: 100 %
What is the age of people who have Intertrigo when taking Amicar? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
What are other drugs people take besides Amicar? *
- Zometa: 9 people, 100.00%
- Furosemide: 9 people, 100.00%
- Ezetimibe: 9 people, 100.00%
- Dilaudid: 9 people, 100.00%
- Ketoconazole: 9 people, 100.00%
- Lanoxin: 9 people, 100.00%
- Lopressor: 9 people, 100.00%
- Lovenox: 9 people, 100.00%
- Digoxin: 9 people, 100.00%
- Morphine: 9 people, 100.00%
What are other side effects people have besides Intertrigo? *
- Wound: 9 people, 100.00%
- Jaundice Cholestatic: 9 people, 100.00%
- Death: 9 people, 100.00%
- Dehydration (dryness resulting from the removal of water): 9 people, 100.00%
- Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 9 people, 100.00%
- Diarrhea: 9 people, 100.00%
- Dizziness: 9 people, 100.00%
- Dyspnea (difficult or laboured breathing): 9 people, 100.00%
- Ejection Fraction Decreased (systolic heart failure): 9 people, 100.00%
- Gallstones (stone formation by bile component): 9 people, 100.00%
What are the existing conditions these people have? *
- High Blood Cholesterol: 9 people, 100.00%
- Haemorrhage (bleeding): 9 people, 100.00%
- Breast Cancer Metastatic: 9 people, 100.00%
- Aortic Valve Incompetence: 9 people, 100.00%
- Neuralgia (pain in one or more nerves): 1 person, 11.11%
- Depression: 1 person, 11.11%
* Approximation only. Some reports may have incomplete information.
Do you take Amicar and have Intertrigo?
- Check whether Intertrigo is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Amicar:
- Amicar (1,323 reports)
Intertrigo treatments and more:
- Intertrigo (1,057 reports)
How severe was Intertrigo and when was it recovered:
Expand to all the drugs that have ingredients of aminocaproic acid:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Amicar:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Intertrigo:
- Intertrigo (169 drugs)
Browse all the conditions that are associated with Intertrigo:
- Intertrigo (207 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on aminocaproic acid (the active ingredients of Amicar) and Amicar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Lopressor and Prevacid 24 Hr - 2 seconds ago
- Could Lasix cause Csf Leak? - 10 seconds ago
- Drug interactions of Evista and Multivitamin - 10 seconds ago
- Phenergan and Lovenox drug interactions for men aged 40-49 - 18 seconds ago
- Drug interactions of Cosopt and Clonazepam - 21 seconds ago
- Drug interactions of Penicillin and Cannabis - 21 seconds ago
- Could Estrace cause Ventricular Tachycardia? - 23 seconds ago
- Paracetamol and Seizures for Men aged 20-29 - 24 seconds ago
- Paracetamol and Seizure for Men aged 20-29 - 24 seconds ago
- Paracetamol and Seizure Control for Men aged 20-29 - 24 seconds ago